Krebs Biochemicals & Industries Ltd. Share Price

Overview

Krebs Biochemicals & Industries Ltd. share price is currently ₹56.19, down by - ₹0.71 (1.25%) from its previous closing price of ₹56.90. The share price has gained 0.7% over the past month and declined -20.46% over the past year. The stock's 52-week low and high are ₹37.74 and ₹75.88, respectively. Krebs Biochemicals & Industries Ltd. has a market capitalisation of ₹ 150.00 Cr. The share price was last updated on 09 Oct 2026, 03:29 PM IST.

Krebs Biochemicals & Industries Ltd.
Krebs Biochemicals & Industries Ltd.
KREBSBIO
 ₹0.00
- ₹0.71
1.25%
Healthcare
 ₹0.00(%)1D

Updated: 09 Oct 2026, 03:29:33 pm IST

Market Data

Open Price

 ₹56.81

Prev. Close

 ₹56.90
 ₹54.41

Day Low

 ₹58.83

Day High

 ₹37.74

52 Week Low

 ₹75.88

52 Week High

HealthcarePharmaceuticals & Drugs
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

-8.59

Sector PE

43.59

PB Ratio

-0.74

Sector PB

5.76

EPS

-6.54

Dividend Yield

0.00

Today's Volume

29.454 K

5 Day Avg. Volume

50.478 K

PEG Ratio

-0.23

Market Cap.

₹ 150.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Krebs Biochemicals & Industries Ltd. 👋

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company's pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Saurab Jain

Saurab Jain

10 Aug • 12:07 PM · SEBI-Registered Analyst

SBI Strong Fundamentals Support Growth Momentum

KREBSBIO
State Bank of India continues to benefit from its strong deposit franchise, diversified loan portfolio and extensive branch network. Growth across retail, corporate and MSME segments remains important for sustaining business momentum, while improving asset quality and controlled credit costs can support profitability. Digital banking initiatives and rising customer engagement are further strengthening operational efficiency. Key factors to monitor include deposit growth, loan expansion, net interest margins, slippages and credit costs. With a strong capital position and broad customer base, SBI remains focused on maintaining sustainable growth while improving efficiency and strengthening its position in India’s banking sector. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link visit website www dot investmentcure dot com *****

See More
SHUBINVESTS I SEBI RA

SHUBINVESTS I SEBI RA

27 Jul • 12:48 PM · SEBI-Registered Analyst

India’s Chemical Reset: The Next Manufacturing Opportunity ?

For years, India's chemical industry has lived with one major weakness—we consume far more chemicals than we produce. India imported nearly $75 billion worth of chemicals while exporting only $44 billion, leaving a trade deficit of $31 billion. A large share of these imports comes from China, especially critical raw materials used in pharmaceuticals, agrochemicals and specialty chemicals. This dependence has become both an economic and strategic concern. To address this, the Government has steadily expanded Quality Control Orders, making BIS certification mandatory for an increasing number of chemical products. The objective is not only to improve product quality but also to encourage domestic manufacturing, reduce low-quality imports and strengthen India's position in global supply chains. The opportunity becomes even bigger when combined with the China+1 strategy. Global companies are increasingly diversifying manufacturing away from China, and India is emerging as an attractive alternative because of its engineering talent, regulatory capabilities and expanding industrial ecosystem. However, the transition will not be smooth. While large integrated companies can absorb compliance costs, many MSMEs may initially face higher expenses and operational challenges before the long-term benefits materialise. • PI Industries

PIIND
– Agrochemicals and CRAMS. • Aarti Industries – Specialty chemicals and pharmaceutical intermediates. • Alkyl Amines Chemicals
ALKYLAMINE
– Amines and specialty intermediates. • Chemicals
KREBSBIO
– Basic chemicals and industrial materials. India's chemical industry may be entering the same transformation phase that sectors like electronics and defence experienced. If policy execution remains balanced and industry continues investing in capacity and technology, the next decade could witness a meaningful shift from import dependence to global manufacturing leadership.

See More
Sumit Kadam

Sumit Kadam

18 May • 1:33 PM · SEBI-Registered Analyst

Market Crash: Panic or Buying Opportunity? 📉

Indian stock markets witnessed heavy selling pressure today as Sensex crashed more than 850 points while Nifty slipped below 23,400. Rising crude oil prices, global tensions, rupee weakness, and foreign investor selling created panic across the market. Investors remained cautious as uncertainty increased in global markets. The stock market works like a roller coaster. During sharp falls, fear spreads quickly and many investors panic sell. However, experienced investors understand that volatility is part of the market cycle and temporary corrections often create long-term opportunities in strong companies. One major reason behind today’s fall was the sharp rise in crude oil prices above $110 per barrel. Higher oil prices increase transportation and production costs for companies and also raise inflation concerns. Weak global sentiment and record-high bond yields also impacted investor confidence during the session. Banking, IT, and auto stocks remained under pressure while defensive sectors showed relatively better stability. For investors, this situation highlights the importance of risk management and patience during uncertain periods. Market corrections may create fear in the short term, but disciplined investing and focusing on fundamentally strong companies remain important for long-term wealth creation. Stocks like RELIANCE, SBIN, INFY, and TCS may remain in focus as investors closely watch crude oil prices, rupee movement, and global market developments. RELIANCE

RELIANCE
SBIN
SBIN
INFY
INFY
TCS
TCS
HDFCBANK
HDFCBANK
Short-term panic can shake markets, but long-term investors focus on opportunities created during corrections. Investors should understand that market corrections are a natural part of investing, and emotional decisions during panic situations can negatively impact long-term financial growth.

See More
Saurab Jain

Saurab Jain

24 Apr • 9:43 PM · SEBI-Registered Analyst

NBCC Riding on Government Projects and Redevelopment Momentum

KREBSBIO
NBCC (India) Limited continues to play a key role in government-led construction and redevelopment projects, benefiting from its strong order book and execution capabilities. Its focus on project management consultancy and redevelopment of prime land parcels provides steady revenue visibility with relatively asset-light operations. Increasing emphasis on urban development and infrastructure initiatives supports long-term growth prospects. However, execution timelines, dependency on government orders, and working capital cycles remain important factors influencing near-term performance and overall earnings outlook. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link

See More
Saurab Jain

Saurab Jain

13 Apr • 8:52 PM · SEBI-Registered Analyst

IOC Refining Strength Amid Volatile Energy Cycle

KREBSBIO
Indian Oil Corporation (IOC) continues to reflect the complex dynamics of the energy sector, where refining margins, crude volatility, and policy direction play a crucial role. The company’s integrated business model—spanning refining, marketing, and petrochemicals—offers operational resilience, especially during periods of fluctuating crude prices. Strategic capex in capacity expansion and energy transition initiatives, including green hydrogen and renewables, signals long-term intent. However, margin sensitivity to global crude movements and government intervention in fuel pricing remain key variables to watch, shaping near-term earnings visibility and overall market sentiment. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link

See More
DEEPAK PAL

DEEPAK PAL

7 Jan • 9:39 AM · SEBI-Registered Analyst

"हल्का लाल इशारा, पर DII का सहारा – आज का बाज़ार range-bound, चुनिंदा स्टॉक्स में ही तमाशा!"

Market Outlook: Flat to Negative Opening with Range-Bound Action Expected Indian markets likely open subdued with GIFT Nifty signaling 15-20 points downside around 26,200 level, reflecting mild global caution after Asian peers show mixed cues and 4-day rally pause. Strong DII buying continues to cushion dips against light FII selling pressure, suggesting buy-on-declines structure persists despite short-term consolidation mode.

INDUSINDBK
AXISBANK
HDFCBANK
KOTAKBANK
Global Cues & Sentiment Global mood remains cautiously optimistic but lacks aggressive momentum. Asian markets trade mixed after recent upmove consolidation, US futures stable overnight. GIFT Nifty's soft pre-open indicates narrow range opening between 26,100-26,250 rather than directional breakout, favoring intraday swing plays over trend-following. Key Stocks Under Radar Today
ONGC
ONGC: Ethane shipping expansion news momentum
ADANIPORTS
Adani Ports: Cargo growth updates
RELIANCE
Reliance: Sector rotation candidate
HDFCBANK
HDFC/ICICI Bank: Banking pivot points Recent momentum names:
IEX
IEX (regulatory relief follow-through), Granules (FDA progress digestion)[conversation_history] Major News Events & Expected Impact Primary Focus: No blockbuster macro events; micro catalysts dominate:
ONGC
ONGC-MOL JV: Positive energy PSU sentiment (mild positive spillover)
ADANIPORTS
Adani Ports cargo data: Infra/logistics rotation trigger (+ve) Q3 Business Updates: Selective IT/pharma names may react to pre-earnings commentary Market Impact: Sector-specific moves expected; index remains range-bound absent global volatility spike.
KREBSBIO
TATACHEM
BRITANNIA

See More

Frequently Asked Questions

What is the share price of Krebs Biochemicals & Industries Ltd.?

What is the market cap of Krebs Biochemicals & Industries Ltd.?

Should I buy Krebs Biochemicals & Industries Ltd. stock now?

What is the 52 week high and low of Krebs Biochemicals & Industries Ltd.?

Is the Krebs Biochemicals & Industries Ltd. stock good to buy?

Is Krebs Biochemicals & Industries Ltd. a good buy for the long term?

Is Krebs Biochemicals & Industries Ltd. overvalued or undervalued?

What is the PE and PB ratio of Krebs Biochemicals & Industries Ltd.?

Start Now